Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Drugs and Chemicals›Methanol
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Methanol

Drugs and Chemicals · NLM MeSH · updated 2026-10-31 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 3 min read

A colorless, flammable liquid used in the manufacture of formaldehyde and acetic acid, in chemical synthesis, antifreeze, and as a solvent.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (620 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

A colorless, flammable liquid used in the manufacture of formaldehyde and acetic acid, in chemical synthesis, antifreeze, and as a solvent. Ingestion of methanol is toxic and may cause blindness.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Alcohol, Methyl; Methyl Alcohol; Carbinol; Wood Alcohol; Alcohol, Wood; Sodium Methoxide; Methoxide, Sodium.

Where it fits in the MeSH classification

Broader topics
Alcohols

Related concepts

  • Formaldehyde
  • Acetic Acid

Research landscape

PubMed indexes 19,525 records tagged with the MeSH heading “Methanol” (counts retrieved 2026-10-31). 3,359 of them (17.2%) were published from 2020 onward, and the busiest period so far is through 1999 with 5,947 records.

Reviews account for 508 records (2.6%) and meta-analyses for 5. Randomized controlled trials number 34 (0.2%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 5,947 records; 2000-2009: 4,281 records; 2010-2019: 5,938 records; 2020 onward: 3,359 records5,947through 19994,2812000-20095,9382010-20193,3592020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19995,947
2000-20094,281
2010-20195,938
2020 onward3,359
Share of records by publication typeReviews: 2.6 percent; Meta-analyses: 0.0 percent; Randomized controlled trials: 0.2 percentReviews2.6% (508)Meta-analyses0.0% (5)Randomized controlled trials0.2% (34)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 19,525 PubMed records
TypeRecordsShare
Reviews5082.6%
Meta-analyses50.0%
Randomized controlled trials340.2%

Method: PubMed query "Methanol"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.

Reading the evidence in drugs and chemicals

Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Homogeneous Catalysis for Sustainable Energy: Hydrogen and Methanol Economies, Fuels from Biomass, and Related Topics
Kumar A, Daw P, Milstein D
2022Review article
Design not recorded in structured metadata
185cc by
PMID 34727501 · DOI · PMC8759071
A modified serine cycle in Escherichia coli coverts methanol and CO2 to two-carbon compounds
Yu H, Liao JC
2018Research article
Design not recorded in structured metadata
132cc by
PMID 30266898 · DOI · PMC6162302
Methanol-essential growth of Escherichia coli
Meyer F, Keller P, Hartl J, Gröninger OG, Kiefer P, Vorholt JA
2018Research article
Design not recorded in structured metadata
122cc by
PMID 29666370 · DOI · PMC5904121
Neuroecology of alcohol risk and reward: Methanol boosts pheromones and courtship success in Drosophila melanogaster
Keesey IW, Doll G, Chakraborty SD, Baschwitz A, Lemoine M, Kaltenpoth M, et al.
2025Research article
Design not recorded in structured metadata
4cc by
PMID 40173238 · DOI · PMC11963984

Homogeneous Catalysis for Sustainable Energy: Hydrogen and Methanol Economies, Fuels from Biomass, and Related Topics [1]

Review article Kumar A, Daw P, Milstein D · · 2022 · cited 185 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
As the world pledges to significantly cut carbon emissions, the demand for sustainable and clean energy has now become more important than ever.
Closing excerpt
Well-defined transition metal complexes, in particular, pincer complexes, have been discussed in more detail due to their high activity and well-studied mechanisms.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (178 words)

As the world pledges to significantly cut carbon emissions, the demand for sustainable and clean energy has now become more important than ever. This includes both production and storage of energy carriers, a majority of which involve catalytic reactions. This article reviews recent developments of homogeneous catalysts in emerging applications of sustainable energy. The most important focus has been on hydrogen storage as several efficient homogeneous catalysts have been reported recently for (de)hydrogenative transformations promising to the hydrogen economy. Another direction that has been extensively covered in this review is that of the methanol economy. Homogeneous catalysts investigated for the production of methanol from CO2, CO, and HCOOH have been discussed in detail. Moreover, catalytic processes for the production of conventional fuels (higher alkanes such as diesel, wax) from biomass or lower alkanes have also been discussed. A section has also been dedicated to the production of ethylene glycol from CO and H2 using homogeneous catalysts. Well-defined transition metal complexes, in particular, pincer complexes, have been discussed in more detail due to their high activity and well-studied mechanisms.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 34727501 · DOI · PMC8759071

A modified serine cycle in Escherichia coli coverts methanol and CO2 to two-carbon compounds [2]

Research article Yu H, Liao JC · · 2018 · cited 132 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Microbial utilization of renewable one-carbon compounds, such as methane, methanol, formic acid, and CO2, has emerged as a potential approach to increase the range of carbon sources for bioproduction and address climate change issues.
Closing excerpt
coli.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (145 words)

Microbial utilization of renewable one-carbon compounds, such as methane, methanol, formic acid, and CO2, has emerged as a potential approach to increase the range of carbon sources for bioproduction and address climate change issues. Here, we modify the natural serine cycle present in methylotrophs and build an adapted pathway for Escherichia coli, which allows microorganism to condense methanol (or formate) together with bicarbonate to produce various products. We introduce the modified cycle into E. coli and demonstrate its capability for one-carbon assimilation through growth complementation and isotope labeling experiments. We also demonstrate conversion of methanol to ethanol by utilizing the modified serine cycle in an engineered E. coli strain, achieving a reaction yet to be accomplished by a one-pot chemical process. This work provides a platform to utilize various renewable one-carbon compounds as carbon sources for biosynthesis through a modified serine cycle in E. coli.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 30266898 · DOI · PMC6162302

Methanol-essential growth of Escherichia coli [3]

Research article Meyer F, Keller P, Hartl J, Gröninger OG, Kiefer P, Vorholt JA · · 2018 · cited 122 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Methanol represents an attractive substrate for biotechnological applications.
Closing excerpt
This study demonstrates a successful metabolic re-routing linked to a heterologous pathway to achieve methanol-dependent growth and represents a crucial step in generating a fully synthetic methylotrophic organism.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (148 words)

Methanol represents an attractive substrate for biotechnological applications. Utilization of reduced one-carbon compounds for growth is currently limited to methylotrophic organisms, and engineering synthetic methylotrophy remains a major challenge. Here we apply an in silico-guided multiple knockout approach to engineer a methanol-essential Escherichia coli strain, which contains the ribulose monophosphate cycle for methanol assimilation. Methanol conversion to biomass was stoichiometrically coupled to the metabolization of gluconate and the designed strain was subjected to laboratory evolution experiments. Evolved strains incorporate up to 24% methanol into core metabolites under a co-consumption regime and utilize methanol at rates comparable to natural methylotrophs. Genome sequencing reveals mutations in genes coding for glutathione-dependent formaldehyde oxidation (frmA), NAD(H) homeostasis/biosynthesis (nadR), phosphopentomutase (deoB), and gluconate metabolism (gntR). This study demonstrates a successful metabolic re-routing linked to a heterologous pathway to achieve methanol-dependent growth and represents a crucial step in generating a fully synthetic methylotrophic organism.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 29666370 · DOI · PMC5904121

Neuroecology of alcohol risk and reward: Methanol boosts pheromones and courtship success in Drosophila melanogaster [4]

Research article Keesey IW, Doll G, Chakraborty SD, Baschwitz A, Lemoine M, Kaltenpoth M, et al. · · 2025 · cited 4 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Attraction of Drosophila melanogaster toward by-products of alcoholic fermentation, especially ethanol, has been extensively studied.
Closing excerpt
Moreover, we demonstrate that methanol can be deadly, and adult flies must therefore accurately weigh the trade-off between benefits and costs for exposure within their naturally fermented and alcohol-rich environments.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (149 words)

Attraction of Drosophila melanogaster toward by-products of alcoholic fermentation, especially ethanol, has been extensively studied. Previous research has provided several interpretations of this attraction, including potential drug abuse, or a self-medicating coping strategy after mate rejection. We posit that the ecologically adaptive value of alcohol attraction has not been fully explored. Here, we assert a simple yet vital biological rationale for this alcohol preference. Flies display attraction to fruits rich in alcohol, specifically ethanol and methanol, where contact results in a rapid amplification of fatty acid-derived pheromones that enhance courtship success. We also identify olfactory sensory neurons that detect these alcohols, where we reveal roles in both attraction and aversion, and show that valence is balanced around alcohol concentration. Moreover, we demonstrate that methanol can be deadly, and adult flies must therefore accurately weigh the trade-off between benefits and costs for exposure within their naturally fermented and alcohol-rich environments.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 40173238 · DOI · PMC11963984

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Heterologous protein expression in the methylotrophic yeast Pichia pastoris [5]
    Cereghino JL, Cregg JM · FEMS Microbiol Rev · 2000 · cited 1,258 times (Europe PMC)
  • Research article American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning [6]
    Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA, American Academy of Clinical Toxicology Ad Hoc Committee on the Treatment Guidelines for Methanol Poisoning · J Toxicol Clin Toxicol · 2002 · cited 346 times (Europe PMC)
  • Research article The expanding world of methylotrophic metabolism [7]
    Chistoserdova L, Kalyuzhnaya MG, Lidstrom ME · Annu Rev Microbiol · 2009 · cited 297 times (Europe PMC)
  • Research article Modularity of methylotrophy, revisited [8]
    Chistoserdova L · Environ Microbiol · 2011 · cited 292 times (Europe PMC)
  • Research article Methanol and ethylene glycol poisonings. Mechanism of toxicity, clinical course, diagnosis and treatment [9]
    Jacobsen D, McMartin KE · Med Toxicol · 1986 · cited 278 times (Europe PMC)
  • Research article Renewable methanol and formate as microbial feedstocks [10]
    Cotton CA, Claassens NJ, Benito-Vaquerizo S, Bar-Even A · Curr Opin Biotechnol · 2020 · cited 233 times (Europe PMC)

References

  1. Kumar A, Daw P, Milstein D. Homogeneous Catalysis for Sustainable Energy: Hydrogen and Methanol Economies, Fuels from Biomass, and Related Topics. . 2022. PMID 34727501 · DOI · PMC8759071
  2. Yu H, Liao JC. A modified serine cycle in Escherichia coli coverts methanol and CO2 to two-carbon compounds. . 2018. PMID 30266898 · DOI · PMC6162302
  3. Meyer F, Keller P, Hartl J, Gröninger OG, Kiefer P, Vorholt JA. Methanol-essential growth of Escherichia coli. . 2018. PMID 29666370 · DOI · PMC5904121
  4. Keesey IW, Doll G, Chakraborty SD, Baschwitz A, Lemoine M, Kaltenpoth M, et al.. Neuroecology of alcohol risk and reward: Methanol boosts pheromones and courtship success in Drosophila melanogaster. . 2025. PMID 40173238 · DOI · PMC11963984
  5. Cereghino JL, Cregg JM. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev. 2000. PMID 10640598 · DOI
  6. Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA, American Academy of Clinical Toxicology Ad Hoc Committee on the Treatment Guidelines for Methanol Poisoning. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002. PMID 12216995 · DOI
  7. Chistoserdova L, Kalyuzhnaya MG, Lidstrom ME. The expanding world of methylotrophic metabolism. Annu Rev Microbiol. 2009. PMID 19514844 · DOI · PMC2827926
  8. Chistoserdova L. Modularity of methylotrophy, revisited. Environ Microbiol. 2011. PMID 21443740 · DOI
  9. Jacobsen D, McMartin KE. Methanol and ethylene glycol poisonings. Mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol. 1986. PMID 3537623 · DOI
  10. Cotton CA, Claassens NJ, Benito-Vaquerizo S, Bar-Even A. Renewable methanol and formate as microbial feedstocks. Curr Opin Biotechnol. 2020. PMID 31733545 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-31.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Acetic AcidDrugs and Chemicals
  • AcetatesDrugs and Chemicals
  • Palmitic AcidDrugs and Chemicals
  • NovobiocinDrugs and Chemicals
  • Butyric AcidDrugs and Chemicals
  • Chenodeoxycholic AcidDrugs and Chemicals

All 546 articles in Drugs and Chemicals →

At a glance

19,525
PubMed records on this heading
17%
published since 2020
508
review articles
34
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-31; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Acetic AcidDrugs and Chemicals
  • AcetatesDrugs and Chemicals
  • Palmitic AcidDrugs and Chemicals
  • NovobiocinDrugs and Chemicals
  • Butyric AcidDrugs and Chemicals

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support